Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, May 3 '25)

Image
By G.M.

 


    Ann Intern Med

  1. BILINSKI A, Emanuel N, Ciaranello A
    Sins of Omission: Model-Based Estimates of the Health Effects of Excluding Pregnant Participants From Randomized Controlled Trials.
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-00689.
    PubMed         Abstract available

  2. YEK C, Mancera AG, Diao G, Walker M, et al
    Impact of the COVID-19 Pandemic on Antibiotic Resistant Infection Burden in U.S. Hospitals : Retrospective Cohort Study of Trends and Risk Factors.
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-03078.
    PubMed         Abstract available

  3. RIDDLER SA, Moodie Z, Clark J, Yen C, et al
    High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-02701.
    PubMed         Abstract available

  4. KIM D, Danpanichkul P, Wijarnpreecha K, Cholankeril G, et al
    Trends in Mortality From Chronic Liver Disease Before, During, and After the COVID-19 Pandemic, 2015 to 2023.
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-03218.
    PubMed        


    BMJ

  5. YUEN ASC, Chen B, Chan AYL, Hayes JF, et al
    Use of gabapentinoid treatment and the risk of self-harm: population based self-controlled case series study.
    BMJ. 2025;389:e081627.
    PubMed         Abstract available


    Clin Infect Dis

  6. CHRISTENSEN A, Nelson Z, Gustafson S, Stoecker R, et al
    Into the Unknown: Practical Remdesivir Restriction in the Era of Widespread SARS-CoV-2 Seropositivity.
    Clin Infect Dis. 2025 Apr 25:ciaf217. doi: 10.1093.
    PubMed         Abstract available

  7. JONES KM, Greene MT, Meddings J, Mantey J, et al
    Impact of a Collaboration-Focused Intervention to Prevent Healthcare-Associated Infections Before and During the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2025 Apr 29:ciaf122. doi: 10.1093.
    PubMed         Abstract available


    Emerg Infect Dis

  8. SPENCER BR, Akinseye A, Grebe E, Stone M, et al
    Self-Reported SARS-CoV-2 Infections among National Blood Donor Cohort, United States, 2020-2022.
    Emerg Infect Dis. 2025;31:1006-1009.
    PubMed         Abstract available

  9. GREBE E, Chacreton D, Stone M, Spencer BR, et al
    Detection of SARS-CoV-2 Reinfections Using Nucleocapsid Antibody Boosting.
    Emerg Infect Dis. 2025;31:958-966.
    PubMed         Abstract available


    Infect Control Hosp Epidemiol

  10. NGAI V, Hsi JB, Singh RD, Mitchell JE, et al
    COVID-19 prevention training with video-based feedback in nursing homes: impact on staff safety behaviors.
    Infect Control Hosp Epidemiol. 2025 Apr 28:1-8. doi: 10.1017/ice.2025.
    PubMed         Abstract available


    Intensive Care Med

  11. PETTENUZZO T, Balzani E, Sella N, Giani M, et al
    Prone positioning during veno-venous extracorporeal membrane oxygenation: a systematic review and meta-analysis.
    Intensive Care Med. 2025 Apr 29. doi: 10.1007/s00134-025-07877.
    PubMed         Abstract available

  12. ESPERATTI M, Fuentes N, Olmos M
    Optimizing non-intubated respiratory support in COVID-19: evaluating the impact of bundle of care strategy on awake prone positioning tolerance. Author's reply.
    Intensive Care Med. 2025 Apr 29. doi: 10.1007/s00134-025-07904.
    PubMed        


    J Infect

  13. DAHL TB, Aftab F, Prebensen C, Berdal JE, et al
    Imidazole propionate is increased in severe COVID-19 and correlates with cardiac involvement.
    J Infect. 2025;90:106494.
    PubMed        

  14. OVERTON CE, Fyles M, Mellor J, Paton RS, et al
    SARS-CoV-2 test sensitivity and duration of positivity in the UK during the 2023/2024 Winter: A prospective cohort study based on self-reported data.
    J Infect. 2025;90:106485.
    PubMed         Abstract available


    J Med Virol

  15. MESSALI S, Bertelli A, Dotta L, Giovanetti M, et al
    Outbreak of Enterovirus D68 in Young Children, Brescia, Italy, August to November 2024.
    J Med Virol. 2025;97:e70372.
    PubMed         Abstract available

  16. TRIFONOV G, Buscher E, Fistera D, Kill C, et al
    Disease Burden of RSV Infection in Adult Patients in Comparison to Influenza Virus Infection.
    J Med Virol. 2025;97:e70373.
    PubMed         Abstract available


    J Virol

  17. SUN H, Yang Q, Zhang Y, Cui S, et al
    Syntaxin-6 restricts SARS-CoV-2 infection by facilitating virus trafficking to autophagosomes.
    J Virol. 2025 Apr 25:e0000225. doi: 10.1128/jvi.00002.
    PubMed         Abstract available

  18. NEGI V, Kuhn RJ
    A BSL-2 chimeric system designed to screen SARS-CoV-2 E protein ion channel inhibitors.
    J Virol. 2025 Apr 30:e0225224. doi: 10.1128/jvi.02252.
    PubMed         Abstract available

  19. ZHANG S, Xu C-L, Wang J, Xiong X, et al
    Spike proteins of coronaviruses activate mast cells for degranulation via stimulating Src/PI3K/AKT/Ca(2+) intracellular signaling cascade.
    J Virol. 2025 Apr 30:e0007825. doi: 10.1128/jvi.00078.
    PubMed         Abstract available


    JAMA

  20. KIANG MV, Bubar KM, Maldonado Y, Hotez PJ, et al
    Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US.
    JAMA. 2025 Apr 24. doi: 10.1001/jama.2025.6495.
    PubMed         Abstract available


    Nature

  21. WANG N, Ji W, Jiao H, Veit M, et al
    A MERS-CoV-like mink coronavirus uses ACE2 as entry receptor.
    Nature. 2025 Apr 30. doi: 10.1038/s41586-025-09007.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »